483 Chinese Peptide Mar 2017

483 Chinese Peptide Mar 2017

Marijo Kambere FDA, Felix Marrero FDA$119.00 - Available Now

FDA investigators audited the Chinese Peptide - Hangzhou, China facility and issued inspectional observations (via FDA 483) on 03 Mar 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 03 Mar 2017
  • Location: Hangzhou, China
  • FEI: 3011559327
Add To Cart